Lukas biomedical Inc.(TW:6814)
NT$17.60+0.10 (+0.57%)
TW:6814
Lukas biomedical Inc. Revenue
NT$17.60
At close:+0.10 (+0.57%)
Lukas biomedical Inc. (6814) Revenue
Lukas biomedical Inc. Revenue
Lukas biomedical Inc. had a revenue of 78.44M in the quarter ending Jun 30, 2026, with -14.34%. This bring the company's revenue in the last twelve months to 170.01M, Decreased 5.28%. In the fiscal year ending Dec 31, 2025, Lukas biomedical Inc. had annual revenue of 179.49M with -5.44% growth.
- Revenue (ttm)
- 170.01M
- Revenue Growth
- -5.72%
- P/S Ratio
- 4.08
- Revenue/Employee
- TWD 2,063,138
- Employees
- 87
- Market Cap
- TWD 732.80M
Revenue Chart
Lukas biomedical Inc. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 179.49M | -10.34M | -5.44% |
| Dec 31, 2024 | 189.83M | -42.01M | -18.12% |
| Dec 31, 2023 | 231.83M | 47.05M | 25.46% |
| Dec 31, 2022 | 184.79M | 27.17M | 17.24% |
| Dec 31, 2021 | 157.62M | -23.79M | -13.12% |
| Dec 31, 2020 | 181.41M | 28.52M | 18.65% |
| Dec 31, 2019 | 152.89M | 20.46M | 15.45% |
| Dec 31, 2018 | 132.43M | 4.08M | 3.18% |
| Dec 31, 2017 | 128.35M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.